Telehealth
Telehealth
DEA Issues Third Extension of Temporary Telemedicine Flexibilities
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to prescribe controlled substances without an…
Health News
GLOBE Model Expected to Have Minimal Impact on Part B OOP Costs
A new analysis published by Avalere Health found that the proposed GLOBE (Global Benchmark for Efficient Drug Pricing) Model would have…




